<DOC>
	<DOCNO>NCT00109785</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure PET scan may improve ability monitor effectiveness chemotherapy locally advance breast cancer . PURPOSE : This clinical trial study well PET scan work patient locally advance breast cancer undergo chemotherapy .</brief_summary>
	<brief_title>PET Scans Patients With Locally Advanced Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether biologic activity locally advance breast cancer measure retention iodine I 124 iododeoxyuridine ( IUdR ) positron emission tomography ( PET ) scan pre- postchemotherapy different patient whose tumor shrink treatment comparison patient whose tumor stable continue grow . - Demonstrate incorporation IUdR tumor tumor DNA 24-36 hour post injection , document tissue analysis immunohistochemistry correlate subsequent change tumor dimension proliferative activity tumor . - Compare pre post treatment result fludeoxyglucose ( FDG ) PET scan IUdR PET scan breast lesion basis assessment relative metabolic change chemotherapy . - Further assess biologic activity metastatic tumor site change size follow chemotherapy standard parameter use evaluate change tumor size , obtain clinical standard care breast cancer , include CT scan well bone scan . - Assess accuracy noninvasive measurement PET measurement leave ventricular cardiac chamber clearance radioactivity substitute arterial plasma sample determine metabolic rate FDG IUdR uptake tumor . - Evaluate metabolic change tumor affect specific chemotherapy comparison change tumor dimension . OUTLINE : For study , chemotherapy administer individual patient discretion patient 's primary attend physician . After chemotherapy , patient evaluate surgical resection tumor . If tumor unresectable , patient may offer radiation therapy . The first group positron emission tomography ( PET ) scan perform within 2 week first dose chemotherapy . The second group PET scan occur 7 week chemotherapy prior local therapy , either surgery radiation therapy . The PET scan initiation chemotherapy consist 4 imaging session . There one iodine I-124 iododeoxyuridine ( IUdR ) PET scan ( 3 image session ) 1 , 4-8 , 24 hour IUdR infusion , follow one fludeoxyglucose ( FDG ) PET scan ( 1 image session ) 45 minute FDG infusion . PROJECTED ACCRUAL : Approximately 20 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Idoxuridine</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm locally advanced breast carcinoma Stage T3 T4 , N2 N3 disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Male female Menopausal status : Not specify Performance status : Karnofsky 80100 % Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No history psychiatric illness would preclude give informed consent Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>male breast cancer</keyword>
</DOC>